From October 1, 2023 to December 31, 2023, the company has repurchased 777,528 shares, representing 0.46% for CNY 82.13 million. With this, the company has completed the repurchase of 1,089,486 shares, representing 0.64% for CNY 117.15 million under the buyback announced on September 27, 2023.
Shanghai Haohai Biological Technology Co., Ltd.
Equities
6826
CNE100001W69
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.4 HKD | -0.12% | -2.82% | +2.73% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.73% | 1.84B | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.11B | |
+3.49% | 40.74B | |
+21.98% | 31.6B | |
+16.38% | 25.56B | |
-5.81% | 24.16B |
- Stock Market
- Equities
- 6826 Stock
- News Shanghai Haohai Biological Technology Co., Ltd.
- Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.